Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for iBio (IBIO) over the last 15 years, with Q4 2025 value amounting to $1.6 million.

  • iBio's Accumulated Expenses fell 1395.1% to $1.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 million, marking a year-over-year decrease of 1395.1%. This contributed to the annual value of $1.3 million for FY2025, which is 3367.85% down from last year.
  • iBio's Accumulated Expenses amounted to $1.6 million in Q4 2025, which was down 1395.1% from $850000.0 recorded in Q3 2025.
  • Over the past 5 years, iBio's Accumulated Expenses peaked at $5.0 million during Q4 2022, and registered a low of $850000.0 during Q3 2025.
  • Its 5-year average for Accumulated Expenses is $2.8 million, with a median of $2.8 million in 2021.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first soared by 17158.37% in 2021, then plummeted by 6823.95% in 2024.
  • Over the past 5 years, iBio's Accumulated Expenses (Quarter) stood at $2.8 million in 2021, then soared by 75.97% to $5.0 million in 2022, then fell by 24.88% to $3.8 million in 2023, then crashed by 51.16% to $1.8 million in 2024, then fell by 13.95% to $1.6 million in 2025.
  • Its Accumulated Expenses stands at $1.6 million for Q4 2025, versus $850000.0 for Q3 2025 and $1.3 million for Q2 2025.